Ahl Investment Management, Inc. Novartis Ag Transaction History

Ahl Investment Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	SELL	$80.03 - $92.81 $16,006 - $18,562	-200 Reduced 2.5%	7,812 $718,000
Q4 2022 Jan 17, 2023	SELL	$75.55 - $92.52 $24,553 - $30,069	-325 Reduced 3.9%	8,012 $0
Q3 2022 Oct 14, 2022	BUY	$74.61 - $87.26 $25,143 - $29,406	337 Added 4.21%	8,337 $634,000
Q2 2022 Jul 20, 2022	BUY	$80.52 - $93.75 $644,160 - $750,000	8,000 New	8,000 $676,000
Q1 2022 Apr 28, 2022	SELL	$80.11 - $90.62 $22,991 - $26,007	-287 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$79.7 - $88.13 $22,873 - $25,293	287 New	287 $25,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Ahl Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Ahl Investment Management, Inc. with notifications on news.